| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0161-6420(02)01041-2 |
| P698 | PubMed publication ID | 12045064 |
| P2093 | author name string | Jimmy M Uddin | |
| Peter D Davies | |||
| P2860 | cites work | Persisting hypotropias following protective ptosis induced by botulinum neurotoxin | Q72459787 |
| Treatment of acquired nystagmus with botulinum neurotoxin A | Q72766532 | ||
| Topical Guanethidine Therapy for Endocrine Lid Retraction | Q72886751 | ||
| Botulinum toxin for the temporary treatment of involutional lower lid entropion: a clinical and morphological study | Q74025260 | ||
| Chemodenervation in treatment of upper eyelid retraction | Q39458930 | ||
| Eyelid surgery in dysthyroid ophthalmopathy | Q39545150 | ||
| The management of blepharospasm and hemifacial spasm | Q44005110 | ||
| Clostridium botulinum toxins: nature and preparation for clinical use. | Q44265430 | ||
| Management of VIth nerve palsy--avoiding unnecessary surgery | Q67981714 | ||
| Botulinum toxin therapy for squint | Q68486781 | ||
| Botulinum toxin A induced protective ptosis | Q68696364 | ||
| Ptosis associated with botulinum toxin treatment of strabismus and blepharospasm | Q69734028 | ||
| Upper eyelid retraction and Graves' disease | Q70170609 | ||
| Botulinum toxin A-induced protective ptosis in corneal disease | Q70216760 | ||
| Injection treatment of endocrine orbital myopathy | Q70643761 | ||
| P433 | issue | 6 | |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 1183-1187 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | Ophthalmology | Q7098109 |
| P1476 | title | Treatment of upper eyelid retraction associated with thyroid eye disease with subconjunctival botulinum toxin injection | |
| P478 | volume | 109 |
| Q48511518 | A Promising Modified Procedure for Upper Eyelid Retraction-Associated Graves' Ophthalmopathy: Transconjunctival Lateral Levator Aponeurectomy. |
| Q47635665 | A single transcutaneous injection with Botox for dysthyroid lid retraction. |
| Q42563364 | Comment on 'Acute thyroid eye disease (TED): principles of medical and surgical management'. |
| Q39848782 | Comparative study of Botox injection treatment for upper eyelid retraction with 6-month follow-up in patients with thyroid eye disease in the congestive or fibrotic stage |
| Q34467124 | Histopathologic analysis of palpebral conjunctiva in thyroid-related orbitopathy (an american ophthalmological society thesis) |
| Q96219330 | Management of Thyroid Eye Disease-Related Strabismus |
| Q46190198 | Management of moderate and severe dysthyroid orbitopathy: about 22 cases |
| Q38130235 | Medical management of thyroid eye disease |
| Q33941058 | Noncosmetic periocular therapeutic applications of botulinum toxin |
| Q33196316 | Retinal detachment from inadvertent intraocular injection of botulinum toxin A. |
| Q26862144 | The evaluation and treatment of graves ophthalmopathy |
| Q36481829 | The graded levator hinge procedure for the correction of upper eyelid retraction (an American Ophthalmological Society thesis). |
| Q53743982 | Thyroid-associated Ophthalmopathy. |
| Q49084302 | Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections. |
| Q37406589 | Update on thyroid eye disease and management. |
| Q80476993 | [Botulinum toxin injection-treatment of upper lid retraction in thyroid eye disease] |
| Q81153976 | [Botulinum toxin treatment for crocodile tears, spastic entropion and for dysthyroid upper eyelid retraction] |
| Q84136157 | [Drug therapy and radiotherapy in Graves' orbitopathy] |
Search more.